Evidence map›Paper›PMID 19101562›Full record

ArticleJournal of molecular and cellular cardiology2009

Stable protein, unstable plaque?

Nicholas E S Sibinga

Abstract readEditorialComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of molecular and cellular cardiology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Nicholas E S Sibinga

Funding

VEGF INDUCED SIGNAL TRANSDUCTIONR01CA086289 · NCI · YESHIVA UNIVERSITY · PI SIBINGA, NICHOLAS E · 1999 to 2009
$2.6M
The Fat1 Cadherin and Vascular RemodelingR01HL088104 · NHLBI · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI SIBINGA, NICHOLAS E · 2008 to 2011
$1.7M
NCI NIH HHS R01 CA086289NHLBI NIH HHS R01 HL088104
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AcetylationAnimalsAtherosclerosisCell LineCollagen Type ICysteine Proteinase InhibitorsDNA-Binding ProteinsHistocompatibility Antigens Class IIHistone Deacetylase 2Histone Deacetylase InhibitorsHistone DeacetylasesHumansHydroxamic AcidsInflammationInterferon-gammaLeupeptinsbenzyloxycarbonylleucyl-leucyl-leucine aldehydeCollagen Type ICysteine Proteinase InhibitorsDNA-Binding ProteinsHdac2 protein, mouseHistocompatibility Antigens Class IIHistone Deacetylase 2Histone Deacetylase InhibitorsHistone DeacetylasesHydroxamic AcidsInterferon-gammaLeupeptinsMHC class II transactivator proteinNuclear ProteinsRegulatory Factor X Transcription FactorsRepressor ProteinsRFX5 protein, humanRFX5 protein, mouseTrans-ActivatorsTranscription Factorstrichostatin A

Identifiers

PMID19101562
PMCPMC2669595

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.